Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

The outbreak of COVID-19 caused by SARS-CoV-2 has resulted in more than 50 million confirmed cases and over 1 million deaths worldwide as of November 2020. Currently, there are no effective antivirals approved by the Food and Drug Administration to contain this pandemic except the antiviral agent re...

Full description

Saved in:

Bibliographic Details
Published in:	Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 5
Main Authors:	Jan, Jia-Tsrong, Cheng, Ting-Jen Rachel, Juang, Yu-Pu, Ma, Hsiu-Hua, Wu, Ying-Ta, Yang, Wen-Bin, Cheng, Cheng-Wei, Chen, Xiaorui, Chou, Ting-Hung, Shie, Jiun-Jie, Cheng, Wei-Chieh, Chein, Rong-Jie, Mao, Shi-Shan, Liang, Pi-Hui, Ma, Che, Hung, Shang-Cheng, Wong, Chi-Huey
Format:	Journal Article
Language:	English
Published:	United States 02.02.2021
Subjects:	Adult Animals Antiviral Agents - chemistry Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Chlorocebus aethiops COVID-19 - drug therapy COVID-19 - epidemiology COVID-19 - virology Cricetinae Disease Models, Animal Drug Repositioning - methods Female Humans Male Pandemics Plant Extracts - pharmacology SARS-CoV-2 - drug effects SARS-CoV-2 - genetics Vero Cells SARS-CoV-2 cell-based and animal studies drug repurposing antiviral
ISSN:	1091-6490, 1091-6490
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!